Active Brain & Nervous System Genetics & Molecular Biology

Prion kinetics and toxicity and their wider relevance in neurodegenerative disease

In plain English

AI plain-English summary

Prion diseases and common dementias like Alzheimer’s share a core mechanism: normal brain proteins clump into fibres called amyloid, which multiply, spread, and damage brain cells. Researchers at the MRC Prion Unit have already shown that prions themselves are not directly toxic—another form of the prion protein is the real culprit. This project will isolate and characterise that toxic species to understand how it kills neurons. The team will also develop faster methods to measure prions and their toxicity. Crucially, they discovered that amyloid seeds from Alzheimer’s can, in rare medical accidents, act like prions and transmit disease in humans. They now find that these seeds exist in different strains, much like classical prions, which may explain why Alzheimer’s progresses differently in different people. This is fundamental science. If successful, it could reveal why some protein aggregates are harmless while others destroy brain tissue, and identify strain-specific targets for therapies. That knowledge might eventually help design drugs that block the toxic species—not just for rare prion diseases, but for the millions affected by Alzheimer’s and other dementias.

View original technical description
It is now recognised that the disease process central to prion diseases – seeded polymerisation of a normal brain protein (the prion protein) to form fibres known as amyloid that multiply and spread throughout the brain and damage brain cells – is of much wider relevance in commoner dementias such as Alzheimer’s disease. Much has been learned from previous work at the Unit in understanding these processes, leading to a General Model of prion propagation and neurotoxicity. An important finding is that prions are not themselves directly toxic to brain cells but rather another prion protein species is the toxic entity. We will isolate and characterise this to understand how it damages brain cells and causes disease and also develop and apply novel methods to rapidly measure prions and prion-related toxicity. Importantly, we discovered that the different types of amyloid involved in causing Alzheimer’s disease can, albeit in rare medical accidents, act as prions and cause Alzheimer’s and other disease in humans. We are finding that these other pathological protein “seeds” resemble classical prions in many ways including existing in different strains which might cause different patterns of human disease. We will identify such strains and seek to understand how they cause disease and how this can help in development of effective therapies.

View the original record at the funder ↗

Researchers

John Collinge (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

Structural studies on mechanisms of prion-like protein assemblies
Cellular pathophysiology of prion-mediated neurodegeneration - a model for understanding protein misfolding disorders
Accumulation of PrP amyloid in vivo that is not infectious
Molecular and phenotypic analysis of prion strains
Role of the prion protein in Alzheimer’s and other neurodegenerative diseases

Original classification

Intramural

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.